Inhibition of lipolysis and muscle protein degradation by epa in cancer cachexia
- 31 January 1996
- Vol. 12 (1) , S31-S33
- https://doi.org/10.1016/0899-9007(95)00066-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumoursEuropean Journal of Clinical Investigation, 1993
- Evidence for the involvement of interleukin 6 in experimental cancer cachexia.Journal of Clinical Investigation, 1992
- Chinese Hamster Ovarian Cells Transfected with the Murine lnterleukin-6 Gene cause Hypercalcemia as well as Cachexia, Leukocytosis and Thrombocytosis in Tumor-Bearing Nude MiceEndocrinology, 1991
- Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with CancerAnnals of Surgery, 1991
- Increased Urinary Excretion of Cortisol and Catecholami-NES in Malnourished Cancer PatientsAnnals of Surgery, 1988
- Cancer CachexiaAnnals of Surgery, 1988
- Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer CachexiaJNCI Journal of the National Cancer Institute, 1988
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Pathogenesis of cachexia in cancer.A review and a hypothesisCancer, 1972